Showing results (331-340 of 722) with videos related to

Sort By:
Pageof 73
The Lancet. Haematology|February 5, 2024
Oral decitabine plus cedazuridine and venetoclax in patients with higher-risk myelodysplastic syndromes or chronic myelomonocytic leukaemia: a single-centre, phase 1/2 studyAlex Bataller, Guillermo Montalban-Bravo, Alexandre Bazinet, et al.
The Lancet. Haematology|March 30, 2024
Riociguat in patients with sickle cell disease and hypertension or proteinuria (STERIO-SCD): a randomised, double-blind, placebo controlled, phase 1-2 trialMark T Gladwin, Victor R Gordeuk, Payal C Desai, et al.
The Lancet. Haematology|September 23, 2024
Venetoclax plus decitabine as a bridge to allogeneic haematopoietic stem-cell transplantation in older patients with acute myeloid leukaemia (VEN-DEC GITMO): final report of a multicentre, single-arm, phase 2 trialDomenico Russo, Nicola Polverelli, Simona Bernardi, et al.
The Lancet. Haematology|September 20, 2024
Decitabine, venetoclax, and ponatinib for advanced phase chronic myeloid leukaemia and Philadelphia chromosome-positive acute myeloid leukaemia: a single-arm, single-centre phase 2 trialNicholas J Short, Daniel Nguyen, Elias Jabbour, et al.
The Lancet. Haematology|September 23, 2024
Sexually transmitted infections in the context of haematological malignanciesTamim Alsuliman, Paolo Musiu, Nicolas Stocker, et al.
The Lancet. Haematology|March 7, 2024
Oral decitabine and cedazuridine plus venetoclax for older or unfit patients with acute myeloid leukaemia: a phase 2 studyAlexandre Bazinet, Guillermo Garcia-Manero, Nicholas Short, et al.
The Lancet. Haematology|March 3, 2024
Haemoglobin thresholds to define anaemia from age 6 months to 65 years: estimates from international data sourcesSabine Braat, Katherine L Fielding, Jiru Han, et al.
The Lancet. Haematology|March 4, 2024
Etranacogene dezaparvovec gene therapy for haemophilia B (HOPE-B): 24-month post-hoc efficacy and safety data from a single-arm, multicentre, phase 3 trialMichiel Coppens, Steven W Pipe, Wolfgang Miesbach, et al.
The Lancet. Haematology|October 28, 2023
Germline predisposition traits in allogeneic hematopoietic stem-cell transplantation for myelodysplastic syndromes: a survey-based study and position paper on behalf of the Chronic Malignancies Working Party of the EBMTCarmelo Gurnari, Marie Robin, Lucy A Godley, et al.
The Lancet. Haematology|October 7, 2023
Comparison of international guideline recommendations for the diagnosis of pulmonary embolismCasper Falster, Maja Hellfritzsch, Thomas Agerbo Gaist, et al.
Pageof 73